Three new studies expand understanding of MAC therapy.
D017963:Azithromycin / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy*; D017828:Rifabutin / Q000627:therapeutic use*; D014605:Uveitis / Q000139:chemically induced
D017828:Rifabutin; D017963:Azithromycin; D017291:Clarithromycin